Fisher & Paykel Healthcare Corporation
Fisher & Paykel Healthcare is a global leader in the design, manufacturing and marketing of medical devices, with a focus on innovative products for respiratory care, acute care, surgery and obstructive sleep apnoea.
Products are manufactured in NZ and Mexico and are primarily sold to hospitals and healthcare facilities around the world through an extensive distribution network.
F&P is listed on both the NZX and ASX and is one of the largest listed companies on the NZX in terms of market capitalisation. The company employs over 5,000 people and is a leader in research and development, investing more than $100 million a year into innovation. Lewis Gradon took over as CEO in 2016.
Company Details
Registered Office:
15 Maurice Paykel Place, East Tamaki, Auckland 2013
Postal Address:
PO Box 14348, Panmure, Auckland 1741
Telephone:
+64 9 574 0100
Facsimile:
+64 9 574 0158
Website:
http://www.fphcare.co.nz/
First Listed:
01/11/1979
Balance Date:
31 March
AGM:
29/08/2023
Directors and Executives
Michael Daniell
Director
Lewis Gradon
Chief Executive Officer and Managing Director
Pip Greenwood
Independent Non-Executive Director
Scott St John
Chair
Raelene Leonard
General Counsel / Company Secretary
Lisa McIntyre
Independent Non-Executive Director
Graham McLean
Independent Non-Executive Director
Neville Mitchell
Independent Non-Executive Director
Cather Simpson
Independent Non-Executive Director
Lyndal York
Chief Financial Officer
Announcements
| Title | Date | Type |
|---|---|---|
| New US tariffs announced today | Thu, Apr 03 2025 10:31 am | GENERAL |
| Capital Change Notice - North America ESPP | Thu, Apr 03 2025 09:11 am | SECISSUE |
| FPH launches F&P Nova™ Nasal mask in NZ and AU | Wed, Mar 12 2025 08:33 am | GENERAL |
| Ongoing Disclosure Notices – Employee Share Purchase Plan | Tue, Mar 11 2025 01:28 pm | SHINTR |
| FPH enters into construction contract for fifth NZ building | Thu, Mar 06 2025 08:30 am | GENERAL |
| SPH Notice - Hyperion Asset Management Limited | Tue, Mar 04 2025 08:35 am | SHINTR |
| SPH Notice - Mitsubishi UFJ Financial Group, Inc. | Fri, Feb 28 2025 05:00 pm | SHINTR |
| Ongoing Disclosure Notice - Ordinary Shares | Fri, Feb 21 2025 08:30 am | SHINTR |
| SPH Notice - Mitsubishi UFJ Financial Group | Mon, Feb 17 2025 04:39 pm | SHINTR |
| Costs forecast to increase under new US tariff regime | Mon, Feb 03 2025 08:30 am | MKTUPDTE |
Major Holdings Announcements
| Date | Name | No. Held | % | Current |
|---|---|---|---|---|
| 16/10/23 | Pinnacle Investment Management Grou | 36,059,206 | 5.09 | 6.20 |
| 13/10/23 | Hyperion Asset Management Limited | 35,452,466 | 5.07 | 6.09 |
| 05/09/23 | Mitsubishi UFJ Financial Group, Inc | 48,116,648 | 7.25 | 8.27 |
| 03/08/21 | The Vanguard Group, Inc. | 21,144,194 | 5.26 | 3.67 |
| 13/07/21 | BlackRock, Inc. and related bodies | 37,908,016 | 5.01 | 6.58 |
| 17/08/20 | The Capital Group Companies, Inc. | 27,621,429 | 5.36 | 4.80 |
| 04/12/17 | Bennelong Funds Management Group Pt | 28,250,795 | 5.00 | 4.95 |
| 22/06/17 | Northcape Capital Pty Limited | 28,174,622 | 5.01 | 4.96 |
Director’s Interests Announcements
| Date | Name | No. Held | % | Details | Other |
|---|---|---|---|---|---|
| 20/12/23 | Scott A. St John | 22,569 | - | - | - |
| 20/12/23 | Lisa Margaret McIntyre | 10,155 | - | - | - |
| 20/12/23 | Lyndal Jane York | 9,573 | - | - | - |
| 20/12/23 | Neville John Mitchell | 7,385 | - | - | - |
| 20/12/23 | Donal ODwyer | 73,418 | - | - | - |
| 30/10/23 | Lewis George Gradon | 578,556 | - | - | - |
| 13/09/22 | Miriam Cather Simpson | 1,250 | - | - | - |
| 06/07/20 | Michael Grenfell Daniel | 900,168 | - | - | - |
| 15/10/19 | Geraldine Celia McBride | 1,262 | - | - | - |
| 08/01/19 | Antony John Carter | 76,102 | - | - | - |
| 12/07/18 | Arthur Morris | 29,695 | - | - | - |
| 29/12/17 | Antony George Barclay | 150,000 | - | - | - |
| 21/12/17 | Anthony Beverley | 74,962 | - | - | - |
| 01/06/17 | Philippa Greenwood | 3,800 | - | - | - |
Analysts’ Forecasts
| profit2021 | profit2022 | eps2021 | dps2021 | sales2021 | ebit2021 | ebitda2021 | |
|---|---|---|---|---|---|---|---|
| mean | 254.7 | 43.9 | 41.0 | 1,711.6 | 351.9 | 465.5 | |
| high | 254.7 | 43.9 | 41.0 | 1,711.6 | 351.9 | 465.5 | |
| low | 254.7 | 43.9 | 41.0 | 1,711.6 | 351.9 | 465.5 | |
| sample | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
Disclaimer
Data on this page is from BusinessDesk and NZX Ltd for information purposes
only. Details are believed to be accurate but no warranty is given as to
accuracy, timeliness, reliability or completeness. No person should rely on
the contents of the report and all persons should obtain independent
professional advice before acting on any information connected with or
contained in this report.
Last
Updated: 18/12/2023
Markets News
Economy
US tariff risk less than expected for FPH, Jarden says
Jarden says tariff-related impacts on earnings would be "nominal" by 2030.
Markets
Wall Street reels as Trump’s plan sinks markets
The president’s sweeping tariffs proved far more severe than investors predicted.
Economy
Trump’s tariffs may spur a more dovish RBNZ
The risk appears more weighted to the RBNZ cutting the OCR further than otherwise.
Primary Sector
United States tariffs: NZ's hit could have been a lot worse
Open Country's boss believes NZ needs to “keep our noses clean" going forward.
